AU2001235636A1 - Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis - Google Patents

Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis

Info

Publication number
AU2001235636A1
AU2001235636A1 AU2001235636A AU3563601A AU2001235636A1 AU 2001235636 A1 AU2001235636 A1 AU 2001235636A1 AU 2001235636 A AU2001235636 A AU 2001235636A AU 3563601 A AU3563601 A AU 3563601A AU 2001235636 A1 AU2001235636 A1 AU 2001235636A1
Authority
AU
Australia
Prior art keywords
leptospire
diagnosing
protein
preventing
treating animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235636A
Inventor
Genevieve Andre-Fontaine
Christine Branger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virbac SA
Ecole Nationale Veterinaire de Nantes
Original Assignee
ENVT TOULOUSE
Virbac SA
Ecole Nationale Veterinaire de Nantes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ENVT TOULOUSE, Virbac SA, Ecole Nationale Veterinaire de Nantes filed Critical ENVT TOULOUSE
Publication of AU2001235636A1 publication Critical patent/AU2001235636A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001235636A 2000-02-08 2001-02-08 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis Abandoned AU2001235636A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0001527A FR2804685B1 (en) 2000-02-08 2000-02-08 USE OF A LEPTOSPIRE PROTEIN FOR THE PREVENTION AND / OR DIAGNOSIS AND / OR TREATMENT OF ANIMAL AND / OR HUMAN LEPTOSPIROSIS
FR0001527 2000-02-08
PCT/FR2001/000373 WO2001059123A1 (en) 2000-02-08 2001-02-08 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis

Publications (1)

Publication Number Publication Date
AU2001235636A1 true AU2001235636A1 (en) 2001-08-20

Family

ID=8846749

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235636A Abandoned AU2001235636A1 (en) 2000-02-08 2001-02-08 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis

Country Status (5)

Country Link
US (1) US20030124567A1 (en)
EP (1) EP1254233A1 (en)
AU (1) AU2001235636A1 (en)
FR (1) FR2804685B1 (en)
WO (1) WO2001059123A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565080B1 (en) * 2002-10-10 2014-01-15 Cornell Research Foundation, Inc. Novel immunogenic proteins of leptospira
FR2846658B1 (en) * 2002-10-30 2007-03-30 Virbac PEPTIDES FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF ANIMAL AND / OR HUMAN LEPTOSPIROSIS.
GB201015223D0 (en) * 2010-09-13 2010-10-27 Sec Dep For Environment Food A Vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306623B1 (en) * 1998-02-24 2001-10-23 The University Of California Leptospiral major outer membrane protein LipL32

Also Published As

Publication number Publication date
FR2804685B1 (en) 2004-08-13
EP1254233A1 (en) 2002-11-06
WO2001059123A1 (en) 2001-08-16
US20030124567A1 (en) 2003-07-03
FR2804685A1 (en) 2001-08-10

Similar Documents

Publication Publication Date Title
HUP0103236A2 (en) Skin and tissue care and/or treatment agent
EP1053041A4 (en) Assessment and control of acoustic tissue effects
AU2003241467A1 (en) Device and method of use for functional isolation of animal or human tissues
AU2512901A (en) Implant for the closing of defect openings in the body of a human or animal and a system for the placement of such an implant
HK1023832A1 (en) Clinical and/or surgical training apparatus
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
AU9314598A (en) Daisy-chainable sensors and stimulators for implantation in living tissue
PL327467A1 (en) Soft treated hygienic tissue
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU3725699A (en) Implantable tissue fastener and system for treating gastroesophageal reflux disease
AU2424097A (en) Living tissue stimulation and recording techniques
AU2981099A (en) Treatment of compulsive behaviours in man and animals
AU3547097A (en) Flexible and expansible internal vascular prosthesis for surgical use
AU6243799A (en) Verification of human medical data
AU2001242490A1 (en) Device for treating human and/or animal tissue
EP1161451A4 (en) Human endokine alpha and methods of use
AU2001235636A1 (en) Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis
AU2002244727A1 (en) Absorbent body and animal litter
AU1438499A (en) Hair and/or body hygienic product for human beings and animals
AU5388299A (en) Antibodies for use in targeted and temporary treatment of humans and animals
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
AU9633998A (en) Sanitary treatment of a sleeping mattress and associated device
AU6504698A (en) Device for treating the human body using coloured and sound waves